UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan

International journal of hematology, 2022, Vol.115 (1), p.11-20

2022

Volltextzugriff (PDF)

Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant

International journal of hematology, 2022-07, Vol.116 (1), p.152-154

2022

Volltextzugriff (PDF)

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

Journal of Clinical and Experimental Hematopathology, 2024, pp.24021

2024

Volltextzugriff (PDF)

Classical Hodgkin Lymphoma Occurring in Association with Progressive Transformation of Germinal Center

Journal of Clinical and Experimental Hematopathology, 2014, Vol.54(3), pp.205-209

2014

Volltextzugriff (PDF)

COVID-19 and antiphospholipid antibodies

Nihon Kessen Shiketsu Gakkai shi, 2021, Vol.32 (5), p.625-627, Article 2021_JJTH_32_5_625-627

2021

Volltextzugriff (PDF)

The Relationship between Molecular Response of BCR-ABL1 Transcripts within 6 Months and Deep Molecular Response at 18 Months to Dasatinib Treatment for Newly Diagnosed Patients with CML-CP

Blood, 2019-11, Vol.134 (Supplement_1), p.2928-2928

2019

Volltextzugriff (PDF)

Current status of anticoagulant therapy and development of coagulation factor XI(a) inhibitors

Nihon Kessen Shiketsu Gakkai shi, 2020, Vol.31 (6), p.619-623

2020

Volltextzugriff (PDF)

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using E uropean L eukemia N et 2013 criteria

European journal of haematology, 2015-12, Vol.95 (6), p.558-565

2015

Volltextzugriff (PDF)

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

Blood, 2013-11, Vol.122 (21), p.4027-4027

2013

Volltextzugriff (PDF)

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria

European journal of haematology, 2015-12, Vol.95 (6), p.558-565

2015

Volltextzugriff (PDF)

Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor

Annals of hematology, 2012-11, Vol.91 (11), p.1825-1826

2012

Volltextzugriff (PDF)

Classical Hodgkin Lymphoma Occurring in Association with Progressive Transformation of Germinal Center

Journal of Clinical and Experimental Hematopathology, 2014-12, Vol.54 (3), p.205-209

2014

Volltextzugriff (PDF)

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Blood, 2011-11, Vol.118 (21), p.4444-4444

2011

Volltextzugriff (PDF)

Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia

International journal of hematology, 1995-06, Vol.61 (4), p.229

1995

Volltextzugriff (PDF)

Primary malignant lymphoma of the ureter: a case report

Hinyokika kiyo. Acta urologica Japonica, 2004-10, Vol.50 (10), p.721

2004

Volltextzugriff (PDF)

Spontaneous regression of malignant lymphoma of the lumbar spine

Skeletal radiology, 2002-02, Vol.31 (2), p.99-102

2002

Volltextzugriff (PDF)

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

Cancer, 1996-08, Vol.78 (3), p.422-426

1996

Volltextzugriff (PDF)

Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia

Rinshō ketsueki, 1999-11, Vol.40 (11), p.1174

1999

Volltextzugriff (PDF)

Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor

Annals of hematology, 2012, Vol.91 (11), p.1825-1826

2012

Volltextzugriff (PDF)

Hemophagocytic syndrome due to miliary tuberculosis in the course of aplastic anemia

Rinshō ketsueki, 1998-05, Vol.39 (5), p.392

1998

Volltextzugriff (PDF)

Hematological stability under ubenimex monotherapy in a patient with acute myelogenous leukemia developing marrow karyotypic changes during the course

Rinshō ketsueki, 1995-11, Vol.36 (11), p.1289

1995

Volltextzugriff (PDF)

Morphological observation of a process of bone marrow hypoplastic formation in a case of aplastic anemia

Rinshō ketsueki, 1995-10, Vol.36 (10), p.1157

1995

Volltextzugriff (PDF)

Early establishment of bone marrow hypoplasia by antileukemic chemotherapy with concurrent rhG-CSF in a case of acute myelogenous leukemia complicated with intestinal perforation

Rinshō ketsueki, 1997-01, Vol.38 (1), p.41

1997

Volltextzugriff (PDF)

Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies

Rinshō ketsueki, 1996-01, Vol.37 (1), p.22

1996

Volltextzugriff (PDF)

Initiation of hematopoietic recovery by recombinant human granulocyte-macrophage colony-stimulating factor in a case of severe aplastic anemia induced by gold salt

Rinshō ketsueki, 1995-01, Vol.36 (1), p.23

1995

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Life Sciences & Biomedicine
(84)
Humans
(77)
Male
(51)
Gastroenterology & Hepatology
(46)
Female
(37)
Middle Aged
(37)
Aged
(25)
Biological And Medical Sciences
(22)
Adult
(21)
Animals
(19)
Medical Sciences
(19)
Medicine
(18)
Autoimmune Pancreatitis
(16)
Gastroenterology
(16)
Hepatology
(16)
Medicine & Public Health
(16)
Autoimmune Diseases - Diagnosis
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Pancreas
(17)
Journal Of Gastroenterology
(15)
Pancreatology : Official Journal Of The International Association Of Pancreatology
(11)
Gastroenterology
(10)
Rinsho Ketsueki
(7)
Rinshō Ketsueki
(7)
膵臓
(6)
Pancreatology
(5)
Suizo
(5)
Suizō
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan

Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

Classical Hodgkin Lymphoma Occurring in Association with Progressive Transformation of Germinal Center

COVID-19 and antiphospholipid antibodies

The Relationship between Molecular Response of BCR-ABL1 Transcripts within 6 Months and Deep Molecular Response at 18 Months to Dasatinib Treatment for Newly Diagnosed Patients with CML-CP

Current status of anticoagulant therapy and development of coagulation factor XI(a) inhibitors

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using E uropean L eukemia N et 2013 criteria

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria

Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor

Classical Hodgkin Lymphoma Occurring in Association with Progressive Transformation of Germinal Center

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia

Primary malignant lymphoma of the ureter: a case report

Spontaneous regression of malignant lymphoma of the lumbar spine

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia

Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor

Hemophagocytic syndrome due to miliary tuberculosis in the course of aplastic anemia

Hematological stability under ubenimex monotherapy in a patient with acute myelogenous leukemia developing marrow karyotypic changes during the course

Morphological observation of a process of bone marrow hypoplastic formation in a case of aplastic anemia

Early establishment of bone marrow hypoplasia by antileukemic chemotherapy with concurrent rhG-CSF in a case of acute myelogenous leukemia complicated with intestinal perforation

Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies

Initiation of hematopoietic recovery by recombinant human granulocyte-macrophage colony-stimulating factor in a case of severe aplastic anemia induced by gold salt

Suchergebnisse filtern